Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C.

PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

2.

Pro-inflammatory Monocyte Phenotype and Cell-Specific Steroid Signaling Alterations in Unmedicated Patients With Major Depressive Disorder.

Hasselmann H, Gamradt S, Taenzer A, Nowacki J, Zain R, Patas K, Ramien C, Paul F, Wingenfeld K, Piber D, Gold SM, Otte C.

Front Immunol. 2018 Nov 23;9:2693. doi: 10.3389/fimmu.2018.02693. eCollection 2018.

3.

Sex differences in autoimmune disorders of the central nervous system.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA.

Semin Immunopathol. 2019 Mar;41(2):177-188. doi: 10.1007/s00281-018-0723-8. Epub 2018 Oct 25.

PMID:
30361800
4.

Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis.

Pöttgen J, Moss-Morris R, Wendebourg JM, Feddersen L, Lau S, Köpke S, Meyer B, Friede T, Penner IK, Heesen C, Gold SM.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):970-976. doi: 10.1136/jnnp-2017-317463. Epub 2018 Mar 16.

PMID:
29549193
5.

T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder.

Patas K, Willing A, Demiralay C, Engler JB, Lupu A, Ramien C, Schäfer T, Gach C, Stumm L, Chan K, Vignali M, Arck PC, Friese MA, Pless O, Wiedemann K, Agorastos A, Gold SM.

Front Immunol. 2018 Feb 20;9:291. doi: 10.3389/fimmu.2018.00291. eCollection 2018.

6.

Implant Failure Rates and Cost Analysis of Contoured Locking Versus Conventional Plate Fixation of Distal Fibula Fractures.

Moss LK, Kim-Orden MH, Ravinsky R, Hoshino CM, Zinar DM, Gold SM.

Orthopedics. 2017 Nov 1;40(6):e1024-e1029. doi: 10.3928/01477447-20171012-05. Epub 2017 Oct 23.

PMID:
29058759
7.

Aberrant peak lactate response in MS.

Schlüter K, Maier J, Patra S, Gold SM, Heesen C, Schulz KH.

NeuroRehabilitation. 2017;41(4):811-822. doi: 10.3233/NRE-172182.

PMID:
29036843
8.

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.

Weygandt M, Wakonig K, Behrens J, Meyer-Arndt L, Söder E, Brandt AU, Bellmann-Strobl J, Ruprecht K, Gold SM, Haynes JD, Paul F.

Mult Scler. 2018 Aug;24(9):1163-1173. doi: 10.1177/1352458517717089. Epub 2017 Jun 28.

PMID:
28657480
9.

Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework.

Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, Otte C.

Lancet Psychiatry. 2017 Sep;4(9):725-732. doi: 10.1016/S2215-0366(17)30153-0. Epub 2017 Apr 7. Review.

PMID:
28396067
10.

Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy.

Engler JB, Kursawe N, Solano ME, Patas K, Wehrmann S, Heckmann N, Lühder F, Reichardt HM, Arck PC, Gold SM, Friese MA.

Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E181-E190. doi: 10.1073/pnas.1617115114. Epub 2017 Jan 3.

11.
12.

Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Weygandt M, Meyer-Arndt L, Behrens JR, Wakonig K, Bellmann-Strobl J, Ritter K, Scheel M, Brandt AU, Labadie C, Hetzer S, Gold SM, Paul F, Haynes JD.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13444-13449. Epub 2016 Nov 7.

13.

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

Chavarro VS, Mealy MA, Simpson A, Lacheta A, Pache F, Ruprecht K, Gold SM, Paul F, Brandt AU, Levy M.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 24;3(6):e286. eCollection 2016 Dec.

14.

Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.

Briken S, Rosenkranz SC, Keminer O, Patra S, Ketels G, Heesen C, Hellweg R, Pless O, Schulz KH, Gold SM.

J Neuroimmunol. 2016 Oct 15;299:53-58. doi: 10.1016/j.jneuroim.2016.08.007. Epub 2016 Aug 5.

PMID:
27725121
15.

Major depressive disorder.

Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF.

Nat Rev Dis Primers. 2016 Sep 15;2:16065. doi: 10.1038/nrdp.2016.65. Review.

PMID:
27629598
16.

Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Gold SM, Voskuhl RR.

Semin Immunopathol. 2016 Nov;38(6):709-718. Epub 2016 Aug 8. Review.

PMID:
27501960
17.

Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.

Ramien C, Taenzer A, Lupu A, Heckmann N, Engler JB, Patas K, Friese MA, Gold SM.

Neurosci Biobehav Rev. 2016 Aug;67:137-46. doi: 10.1016/j.neubiorev.2015.12.015. Epub 2016 Jan 8. Review.

PMID:
26773723
18.

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.

Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM.

Mult Scler. 2016 Oct;22(11):1476-1484. Epub 2016 Jan 8.

PMID:
26746809
19.

Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.

Fischer A, Fischer M, Nicholls RA, Lau S, Poettgen J, Patas K, Heesen C, Gold SM.

Brain Behav. 2015 Sep;5(9):e00365. doi: 10.1002/brb3.365. Epub 2015 Jul 14.

20.

An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.

Fischer A, Schröder J, Vettorazzi E, Wolf OT, Pöttgen J, Lau S, Heesen C, Moritz S, Gold SM.

Lancet Psychiatry. 2015 Mar;2(3):217-23. doi: 10.1016/S2215-0366(14)00049-2. Epub 2015 Feb 25.

PMID:
26359900
21.

Changes of Motivational Variables in Patients with Multiple Sclerosis in an Exercise Intervention: Associations between Physical Performance and Motivational Determinants.

Geertz W, Dechow AS, Patra S, Heesen C, Gold SM, Schulz KH.

Behav Neurol. 2015;2015:248193. doi: 10.1155/2015/248193. Epub 2015 Jul 12.

22.

Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.

Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.

Neuroimage Clin. 2014 Dec 27;8:440-7. doi: 10.1016/j.nicl.2014.12.015. eCollection 2015.

23.

Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.

Michailidou I, Willems JG, Kooi EJ, van Eden C, Gold SM, Geurts JJ, Baas F, Huitinga I, Ramaglia V.

Ann Neurol. 2015 Jun;77(6):1007-26. doi: 10.1002/ana.24398. Epub 2015 May 11.

PMID:
25727254
24.

Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.

Blum K, Febo M, McLaughlin T, Cronjé FJ, Han D, Gold SM.

J Behav Addict. 2014 Sep;3(3):149-56. doi: 10.1556/JBA.3.2014.019. Epub 2014 Aug 26. Review.

25.

Steroid regulation of T cell function appears unaltered in borderline personality disorder.

Fischer A, Grundmann J, Gold SM, Spitzer C, Wingenfeld K.

J Pers Disord. 2015 Apr;29(2):241-7. doi: 10.1521/pedi_2014_28_156. Epub 2014 Sep 23.

PMID:
25248018
26.

Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.

Briken S, Gold SM, Patra S, Vettorazzi E, Harbs D, Tallner A, Ketels G, Schulz KH, Heesen C.

Mult Scler. 2014 Mar;20(3):382-90. doi: 10.1177/1352458513507358. Epub 2013 Oct 24.

PMID:
24158978
27.

Depressive syndromes in neurological disorders.

Hellmann-Regen J, Piber D, Hinkelmann K, Gold SM, Heesen C, Spitzer C, Endres M, Otte C.

Eur Arch Psychiatry Clin Neurosci. 2013 Nov;263 Suppl 2:S123-36. Review.

PMID:
24077889
28.

Complications following tension-band fixation of patellar fractures with cannulated screws compared with Kirschner wires.

Hoshino CM, Tran W, Tiberi JV, Black MH, Li BH, Gold SM, Navarro RA.

J Bone Joint Surg Am. 2013 Apr 3;95(7):653-9. doi: 10.2106/JBJS.K.01549.

PMID:
23553301
29.

Association between cortisol awakening response and memory function in major depression.

Hinkelmann K, Muhtz C, Dettenborn L, Agorastos A, Moritz S, Wingenfeld K, Spitzer C, Gold SM, Wiedemann K, Otte C.

Psychol Med. 2013 Nov;43(11):2255-63. doi: 10.1017/S0033291713000287. Epub 2013 Feb 27.

PMID:
23442784
30.

Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.

Patas K, Engler JB, Friese MA, Gold SM.

J Reprod Immunol. 2013 Mar;97(1):140-6. doi: 10.1016/j.jri.2012.10.005. Review.

PMID:
23432880
31.

Comparison of patient-reported outcome measures in multiple sclerosis.

Schäffler N, Schönberg P, Stephan J, Stellmann JP, Gold SM, Heesen C.

Acta Neurol Scand. 2013 Aug;128(2):114-21. doi: 10.1111/ane.12083. Epub 2013 Feb 7.

PMID:
23398571
32.

Impaired social cognition in multiple sclerosis.

Pöttgen J, Dziobek I, Reh S, Heesen C, Gold SM.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):523-8. doi: 10.1136/jnnp-2012-304157. Epub 2013 Jan 11.

PMID:
23315621
33.

[Depression and neurological diseases].

Piber D, Hinkelmann K, Gold SM, Heesen C, Spitzer C, Endres M, Otte C.

Nervenarzt. 2012 Nov;83(11):1423-33. doi: 10.1007/s00115-012-3674-7. Review. German.

PMID:
23095843
34.

Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.

Heesen C, Köpke S, Kasper J, Poettgen J, Tallner A, Mohr DC, Gold SM.

Expert Rev Neurother. 2012 Sep;12(9):1089-100. doi: 10.1586/ern.12.103. Review.

PMID:
23039388
35.

Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Gold SM, O'Connor MF, Gill R, Kern KC, Shi Y, Henry RG, Pelletier D, Mohr DC, Sicotte NL.

Hum Brain Mapp. 2014 Jan;35(1):30-7. doi: 10.1002/hbm.22154. Epub 2012 Jul 30.

36.

Don't stress about it! Is stress management a disease-modifying therapy for multiple sclerosis?

Heesen C, Gold SM.

Neurology. 2012 Jul 31;79(5):398-9. doi: 10.1212/WNL.0b013e3182617181. Epub 2012 Jul 11. No abstract available.

PMID:
22786585
37.

Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation.

Gold SM, Sasidhar MV, Lagishetty V, Spence RD, Umeda E, Ziehn MO, Krieger T, Schulz KH, Heesen C, Hewison M, Voskuhl RR.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1402-10. doi: 10.1210/jc.2012-1294. Epub 2012 Jun 1.

38.

The XX sex chromosome complement in mice is associated with increased spontaneous lupus compared with XY.

Sasidhar MV, Itoh N, Gold SM, Lawson GW, Voskuhl RR.

Ann Rheum Dis. 2012 Aug;71(8):1418-22. doi: 10.1136/annrheumdis-2011-201246. Epub 2012 May 12.

39.

Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.

Fischer A, Otte C, Krieger T, Nicholls RA, Krüger S, Ziegler KJ, Schulz KH, Heesen C, Gold SM.

Psychoneuroendocrinology. 2012 Oct;37(10):1712-8. doi: 10.1016/j.psyneuen.2012.03.001. Epub 2012 Mar 27.

PMID:
22455832
40.

Sex-related factors in multiple sclerosis susceptibility and progression.

Voskuhl RR, Gold SM.

Nat Rev Neurol. 2012 Mar 27;8(5):255-63. doi: 10.1038/nrneurol.2012.43. Review.

41.

Childhood trauma in multiple sclerosis: a case-control study.

Spitzer C, Bouchain M, Winkler LY, Wingenfeld K, Gold SM, Grabe HJ, Barnow S, Otte C, Heesen C.

Psychosom Med. 2012 Apr;74(3):312-8. doi: 10.1097/PSY.0b013e31824c2013. Epub 2012 Mar 9.

PMID:
22408134
42.

Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

MacKenzie-Graham A, Rinek GA, Avedisian A, Gold SM, Frew AJ, Aguilar C, Lin DR, Umeda E, Voskuhl RR, Alger JR.

Neuroimage. 2012 Mar;60(1):95-104. doi: 10.1016/j.neuroimage.2011.11.099. Epub 2011 Dec 13.

43.

Biological outcome measurements for behavioral interventions in multiple sclerosis.

Fischer A, Heesen C, Gold SM.

Ther Adv Neurol Disord. 2011 Jul;4(4):217-29. doi: 10.1177/1756285611405252.

44.

Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.

Montalban X, Comi G, O'Connor P, Gold S, de Vera A, Eckert B, Kappos L.

Mult Scler. 2011 Nov;17(11):1341-50. doi: 10.1177/1352458511411061. Epub 2011 Jul 4.

PMID:
21727148
45.

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.

Gold SM, Krüger S, Ziegler KJ, Krieger T, Schulz KH, Otte C, Heesen C.

J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):814-8. doi: 10.1136/jnnp.2010.230029. Epub 2011 Feb 4.

PMID:
21296901
46.

Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Gold SM, Kern KC, O'Connor MF, Montag MJ, Kim A, Yoo YS, Giesser BS, Sicotte NL.

Biol Psychiatry. 2010 Sep 15;68(6):553-9. doi: 10.1016/j.biopsych.2010.04.025. Epub 2010 Jun 19.

47.

Correlates of cognitive dysfunction in multiple sclerosis.

Heesen C, Schulz KH, Fiehler J, Von der Mark U, Otte C, Jung R, Poettgen J, Krieger T, Gold SM.

Brain Behav Immun. 2010 Oct;24(7):1148-55. doi: 10.1016/j.bbi.2010.05.006. Epub 2010 May 31.

PMID:
20621641
48.

Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings.

Gold SM, Schulz H, Stein H, Solf K, Schulz KH, Heesen C.

J Neurol Sci. 2010 Mar 15;290(1-2):102-6. doi: 10.1016/j.jns.2009.10.020. Epub 2009 Nov 17.

PMID:
19922955
49.

Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Gold SM, Sasidhar MV, Morales LB, Du S, Sicotte NL, Tiwari-Woodruff SK, Voskuhl RR.

Lab Invest. 2009 Oct;89(10):1076-83. doi: 10.1038/labinvest.2009.79. Epub 2009 Aug 10.

50.

Estrogen and testosterone therapies in multiple sclerosis.

Gold SM, Voskuhl RR.

Prog Brain Res. 2009;175:239-51. doi: 10.1016/S0079-6123(09)17516-7. Review.

Supplemental Content

Loading ...
Support Center